TRiCBIO
Models & ProductsNavigation menu
R&D ServicesModels & ProductsApplicationsTechnologyEvidence & ResourcesHow We WorkAbout TRiCBIOProject inquiry中文
Tailored studiesNormal-tissue organoid

Human endometrial organoid

Track morphology and marker expression from primary establishment and passaging through proliferative, secretory and receptive stages, with epithelial-identity profiling throughout.

E-cadherinKi67ERPRFOXO1
Model source

Human endometrial tissue, with sample context, cycle stage and applicable ethics requirements incorporated into the study design

Culture / format

3D culture · Stage-directed differentiation

Supporting evidence

TRiCBIO human endometrial organoid establishment, passage and stage-characterization data

Study planning

From study objective to model and assay plan

Sample and tissue context, the biological objective and the stages or phenotypes of interest guide culture conditions, assays and deliverables.

01

Sample and tissue context

Sample source, tissue context, cycle or stage information, and available ethics or background documentation.

02

Study focus and conditions

The tissue-biology objective, induction or intervention conditions, and the stages or phenotypes to compare.

03

Assays and deliverables

Planned morphology, histology, molecular or functional assays, with preferred images, data and report formats.

Study design

Design endometrial organoid studies around sample context and stage objectives

Endometrial organoids support studies of tissue source, epithelial identity and stage-associated change. Each study confirms sample context, culture conditions and the tissue question to be answered.

01

Sample and stage assessment

Assess tissue source, cycle or hormonal context, collection and ethics documentation, then define whether the focus is proliferative, secretory, receptive-associated or treatment-related change.

02

Establishment, passage and identity

Use serial bright-field imaging, H&E and E-cadherin/Ki67 profiling to establish model identity and the baseline for stage-focused work.

03

Stage-directed culture and assays

Define culture points per program and combine ER, PR, FOXO1 and other required assays to assess morphology and molecular change.

04

Clear interpretation

Relate baseline model features and stage-dependent biology to treatment-associated changes, then define priorities for functional or translational follow-up.

Study scope

Review sample requirements, assays and deliverables

01

Before the study

  • Sample source and cycle context
  • Hormonal or treatment conditions
  • Stages and endpoints to compare
02

Potential readouts

  • Bright-field, H&E and morphology
  • E-cadherin, Ki67, ER and PR
  • FOXO1 and study-relevant molecular assays
03

What you receive

  • Establishment and passage record
  • Study images and assay results
  • Analysis report and study-design notes

Research applications

Recommended applications

  • Endometrial epithelial biology
  • Stage-dependent differentiation and hormone-response research
  • Candidate response and tissue-injury observation

Assays & QC

Model identity, stage and functional readouts

Key markers

E-cadherinKi67ERPRFOXO1

Available assays

  • Bright-field imaging
  • H&E
  • IF
  • RT-qPCR configured for the study

QC approach

Baseline characterization combines establishment and passaging morphology, H&E, E-cadherin and Ki67, with ER, PR, FOXO1 or other study-relevant markers used to track stage-dependent change.

Study & delivery

Model establishment, characterization and study delivery

Custom studies define the sample, induction conditions, differentiation stages and assays. Deliverables can include images, results, analysis and a study report.

Related solutions

Related study options

PROJECT DISCUSSION

Discuss an endometrial study

Sample and tissue context, study goal, induction or intervention conditions, and stage-specific endpoints determine the model configuration, assay panel and deliverables for the human endometrial organoid.